A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant (NCT01960361) | Clinical Trial Compass
CompletedPhase 4
A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant
Israel35 participantsStarted 2015-01
Plain-language summary
The current prospective clinical study's aim is to determine ABT's ICE implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of ICE implants.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Men and women over the age of 18 years who need implantation of 1-4 implants.
. Patients who are able to understand the requirements of the study, and are willing and able to comply with its instructions and schedules.
. Patients who had provided written informed consent to participate in the study prior to any study procedure.
. Patients in general good health in the opinion of the principal investigator as determined by medical history and oral examination.
Exclusion criteria
. Immediate loaded implants.
. Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.
. Treatment with anticonvulsants drugs.
. Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
. Patients with history of alcohol, narcotics or drug abuse.
. Patients under steroid therapy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
. Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment or who have been administered radiotherapy in the last 5 years.
. Metabolic bone disorders and/or bone augmentation.